A novel rabies vaccine based on infectious propagating particles derived from hybrid VEEV-Rabies replicon

BACKGROUND: Live attenuated vaccines (LAVs) can mimic natural infection and have advantages to stimulate a robust and sustained immune response as well as to confer long-term protection. However, safety concerns is one of the major obstacles for LAVs development. In an effort to achieve the optimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ya-Nan, Chen, Chen, Deng, Cheng-Lin, Zhang, Cheng-guang, Li, Na, Wang, Zhen, Zhao, Ling, Zhang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273168/
https://www.ncbi.nlm.nih.gov/pubmed/32512518
http://dx.doi.org/10.1016/j.ebiom.2020.102819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273168/
https://www.ncbi.nlm.nih.gov/pubmed/32512518
http://dx.doi.org/10.1016/j.ebiom.2020.102819

Ejemplares similares